AI-Bolstered Drug Co. Hits Ch. 11 With $105M Debt

By Emlyn Cameron · August 28, 2026, 5:50 PM EDT

A company that uses artificial intelligence to explore new uses for existing drugs entered bankruptcy in Delaware with over $104 million in debt and a stalking horse bidder....

To view the full article, register now.

Documents

Case Information

Case Title

BioXcel Therapeutics, Inc.

Case Number

1:26-bk-11360

Court

Delaware

Nature of Suit

Date Filed

August 27, 2026